{"id":"https://openalex.org/W2899299145","doi":"https://doi.org/10.3851/imp3277","title":"Differential Extracellular, but Similar Intracellular, Disposition of two Tenofovir Formulations in the Male Genital Tract","display_name":"Differential Extracellular, but Similar Intracellular, Disposition of two Tenofovir Formulations in the Male Genital Tract","publication_year":2018,"publication_date":"2018-10-30","ids":{"openalex":"https://openalex.org/W2899299145","doi":"https://doi.org/10.3851/imp3277","mag":"2899299145","pmid":"https://pubmed.ncbi.nlm.nih.gov/30375984","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7147147"},"language":"en","primary_location":{"id":"doi:10.3851/imp3277","doi":"https://doi.org/10.3851/imp3277","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp3277","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP3277","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","datacite","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP3277","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021388560","display_name":"Julie B. Dumond","orcid":"https://orcid.org/0000-0002-3500-5819","observed_orcids":["https://orcid.org/0000-0002-3500-5819"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Julie B Dumond","raw_affiliation_strings":["UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Stephen A Greene","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117117","display_name":"SK Life Science (United States)","ror":"https://ror.org/025t9c657","country_code":"US","type":"company","lineage":["https://openalex.org/I134353371","https://openalex.org/I4210117117"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen A Greene","raw_affiliation_strings":["Present address: SK Life Science, Inc., Fairlawn, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Present address: SK Life Science, Inc., Fairlawn, NJ, USA","institution_ids":["https://openalex.org/I4210117117"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Heather Prince","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather Prince","raw_affiliation_strings":["UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087089583","display_name":"Jingxian Chen","orcid":"https://orcid.org/0000-0002-3493-5491","observed_orcids":["https://orcid.org/0000-0002-3493-5491"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jingxian Chen","raw_affiliation_strings":["Present address: Merck CO, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Present address: Merck CO, Philadelphia, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061929848","display_name":"Brian M. Maas","orcid":"https://orcid.org/0000-0002-2410-4379","observed_orcids":["https://orcid.org/0000-0002-2410-4379"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian M Maas","raw_affiliation_strings":["Present address: Merck CO, Philadelphia, PA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Present address: Merck CO, Philadelphia, PA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104090749","display_name":"Craig Sykes","orcid":"https://orcid.org/0009-0002-9372-2784","observed_orcids":["https://orcid.org/0009-0002-9372-2784"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig Sykes","raw_affiliation_strings":["UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026144247","display_name":"Amanda P. Schauer","orcid":"https://orcid.org/0000-0002-7026-7224","observed_orcids":["https://orcid.org/0000-0002-7026-7224"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amanda P Schauer","raw_affiliation_strings":["UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063977309","display_name":"Kimberly Blake","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kimberly H Blake","raw_affiliation_strings":["UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110031384","display_name":"Julie A. E. Nelson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie AE Nelson","raw_affiliation_strings":["UNC School of Medicine, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC School of Medicine, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049794472","display_name":"Cynthia L. Gay","orcid":"https://orcid.org/0000-0002-3620-3059","observed_orcids":["https://orcid.org/0000-0002-3620-3059"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cynthia L Gay","raw_affiliation_strings":["UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034242048","display_name":"Angela D. M. Kashuba","orcid":"https://orcid.org/0000-0002-9171-8493","observed_orcids":["https://orcid.org/0000-0002-9171-8493"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Angela DM Kashuba","raw_affiliation_strings":["UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Eshelman School of Pharmacy, Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5024262342","display_name":"Myron S. Cohen","orcid":"https://orcid.org/0000-0001-5917-9664","observed_orcids":["https://orcid.org/0000-0001-5917-9664"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Myron S Cohen","raw_affiliation_strings":["UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC School of Medicine, Department of Internal Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5021388560"],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":{"value":2800,"currency":"USD","value_usd":2800},"apc_paid":null,"fwci":0.5668,"has_fulltext":true,"cited_by_count":8,"citation_normalized_percentile":{"value":0.67579332,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":96},"biblio":{"volume":"24","issue":"1","first_page":"45","last_page":"50"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9717000126838684,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.018200000748038292,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.006000000052154064,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/tenofovir-alafenamide","display_name":"tenofovir alafenamide","score":0.9909999966621399},{"id":"https://openalex.org/keywords/tenofovir-disoproxil-fumarate","display_name":"tenofovir disoproxil fumarate","score":0.9829999804496765},{"id":"https://openalex.org/keywords/emtricitabine","display_name":"emtricitabine","score":0.9169999957084656},{"id":"https://openalex.org/keywords/hiv-cure-strategies","display_name":"HIV cure strategies","score":0.7940000295639038},{"id":"https://openalex.org/keywords/hiv-reservoir","display_name":"HIV reservoir","score":0.8209999799728394},{"id":"https://openalex.org/keywords/hiv-viral-load","display_name":"HIV viral load","score":0.6470000147819519},{"id":"https://openalex.org/keywords/peripheral-blood-mononuclear-cells","display_name":"peripheral blood mononuclear cells","score":0.9459999799728394}],"concepts":[{"id":"https://openalex.org/C137061746","wikidata":"https://www.wikidata.org/wiki/Q736033","display_name":"Peripheral blood mononuclear cell","level":3,"score":0.6876187324523926},{"id":"https://openalex.org/C2779778239","wikidata":"https://www.wikidata.org/wiki/Q422604","display_name":"Emtricitabine","level":5,"score":0.6612744331359863},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.6022665500640869},{"id":"https://openalex.org/C2778093475","wikidata":"https://www.wikidata.org/wiki/Q9715","display_name":"Semen","level":2,"score":0.5277324914932251},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5059193968772888},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.4972894489765167},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4191417098045349},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.39652448892593384},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.37432223558425903},{"id":"https://openalex.org/C16685009","wikidata":"https://www.wikidata.org/wiki/Q335057","display_name":"Andrology","level":1,"score":0.3699052631855011},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3384566903114319},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.26246005296707153},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.13619700074195862},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0770241916179657},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068679","descriptor_name":"Emtricitabine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000068679","descriptor_name":"Emtricitabine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000068698","descriptor_name":"Tenofovir","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000225","descriptor_name":"Adenine","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D001773","descriptor_name":"Blood Cells","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D001773","descriptor_name":"Blood Cells","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005837","descriptor_name":"Genitalia, Male","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007963","descriptor_name":"Leukocytes, Mononuclear","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012661","descriptor_name":"Semen","qualifier_ui":"Q000166","qualifier_name":"cytology","is_major_topic":false},{"descriptor_ui":"D012661","descriptor_name":"Semen","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D060737","descriptor_name":"Reproductive Tract Infections","qualifier_ui":"Q000821","qualifier_name":"virology","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.3851/imp3277","doi":"https://doi.org/10.3851/imp3277","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp3277","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP3277","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},{"id":"pmid:30375984","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/30375984","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral therapy","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7147147","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7147147","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Antivir Ther","raw_type":"Text"},{"id":"pmh:cdr.lib.unc.edu:gt54kz768","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.17615/5bs8-n684","pdf_url":"https://doi.org/10.17615/5bs8-n684","source":{"id":"https://openalex.org/S4306401075","display_name":"Carolina Digital Repository (University of North Carolina at Chapel Hill)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114027177","host_organization_name":"University of North Carolina at Chapel Hill","host_organization_lineage":["https://openalex.org/I114027177"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Antiviral Therapy, 24(1)","raw_type":"Article"},{"id":"doi:10.17615/5bs8-n684","doi":"https://doi.org/10.17615/5bs8-n684","is_oa":true,"landing_page_url":"https://doi.org/10.17615/5bs8-n684","pdf_url":null,"source":{"id":"https://openalex.org/S7407051488","display_name":"UNC Libraries","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.3851/imp3277","doi":"https://doi.org/10.3851/imp3277","is_oa":true,"landing_page_url":"https://doi.org/10.3851/imp3277","pdf_url":"https://journals.sagepub.com/doi/pdf/10.3851/IMP3277","source":{"id":"https://openalex.org/S137629795","display_name":"Antiviral Therapy","issn_l":"1359-6535","issn":["1359-6535","2040-2058"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Antiviral Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G34429661","display_name":"Optimizing Antiretroviral Use in Aging: Pharmacokinetics, Response, and Toxicity","funder_award_id":"K23AI093156","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"},{"id":"https://openalex.org/G4154323457","display_name":"The Compartmental Biology of HIV in the Male Genital Tract","funder_award_id":"R01DK108424","funder_id":"https://openalex.org/F4320337357","funder_display_name":"National Institute of Diabetes and Digestive and Kidney Diseases"},{"id":"https://openalex.org/G6628848920","display_name":"North Carolina Translational and Clinical Science Institute (NC TraCS)","funder_award_id":"UL1TR002489","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G9000894295","display_name":"The University of North Carolina Center for AIDS Research","funder_award_id":"P30AI050410","funder_id":"https://openalex.org/F4320337355","funder_display_name":"National Institute of Allergy and Infectious Diseases"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"},{"id":"https://openalex.org/F4320337357","display_name":"National Institute of Diabetes and Digestive and Kidney Diseases","ror":"https://ror.org/00adh9b73"},{"id":"https://openalex.org/F4320337472","display_name":"National Center for Advancing Translational Sciences","ror":"https://ror.org/04pw6fb54"},{"id":"https://openalex.org/F4320337701","display_name":"North Carolina Translational and Clinical Sciences Institute, University of North Carolina at Chapel Hill","ror":null},{"id":"https://openalex.org/F4320337739","display_name":"UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill","ror":null}],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2899299145.pdf"},"referenced_works_count":20,"referenced_works":["https://openalex.org/W1980031822","https://openalex.org/W1987554589","https://openalex.org/W1997812784","https://openalex.org/W2004290526","https://openalex.org/W2046745323","https://openalex.org/W2049352584","https://openalex.org/W2056210314","https://openalex.org/W2082211638","https://openalex.org/W2093867350","https://openalex.org/W2109478037","https://openalex.org/W2110007855","https://openalex.org/W2120292589","https://openalex.org/W2132692761","https://openalex.org/W2147264567","https://openalex.org/W2151219710","https://openalex.org/W2183163677","https://openalex.org/W2294972389","https://openalex.org/W2326890844","https://openalex.org/W2793835583","https://openalex.org/W4247593499"],"related_works":["https://openalex.org/W4400021862","https://openalex.org/W2563513465","https://openalex.org/W2904182474","https://openalex.org/W2094570617","https://openalex.org/W2507263791","https://openalex.org/W4362522632","https://openalex.org/W3022734382","https://openalex.org/W2176639474","https://openalex.org/W1921422247","https://openalex.org/W1997812784"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1],"male":[2],"genital":[3],"tract":[4],"(MGT)":[5],"is":[6,25,34],"a":[7,35,181,191],"viral":[8,117],"sanctuary":[9],"and":[10,29,50,62,74,78,82,95,105,123,132,146,178,218,227,235],"likely":[11],"HIV":[12,116],"reservoir;":[13],"understanding":[14],"MGT":[15,46],"pharmacokinetics":[16],"(PK)":[17],"of":[18,176,183],"antiretrovirals":[19],"(ARVs)":[20],"used":[21,238],"for":[22,102],"curative":[23],"strategies":[24],"critical":[26],"to":[27,40,152,165,207],"eradication":[28],"cure.":[30],"Tenofovir":[31],"alafenamide":[32],"(TAF)":[33],"tenofovir":[36],"(TFV)":[37],"formulation":[38],"designed":[39],"maximize":[41],"efficacy/minimize":[42],"toxicity":[43],"with":[44,157,160],"unknown":[45],"PK.":[47],"METHODS:":[48],"HIV-positive":[49,127],"HIV-negative":[51,134],"men":[52,136],"receiving":[53],"TFV-based":[54],"regimens":[55],"provided":[56,137],"six":[57],"paired":[58],"blood":[59,91],"plasma":[60,76],"(BP)":[61],"semen":[63],"samples.":[64,138],"Extracellular":[65],"(TFV,":[66],"TAF,":[67],"emtricitabine":[68],"[FTC])":[69],"drug":[70],"concentrations":[71,86,156,163,175,185,203],"in":[72,89,121,215,220,225,239],"BP":[73,122,155,169],"seminal":[75,96],"(SP),":[77],"intracellular":[79],"metabolite":[80],"(IM)":[81],"endogenous":[83],"nucleotide":[84],"(EN)":[85],"were":[87,107,171,180,204,210],"measured":[88,120],"peripheral":[90],"mononuclear":[92,97],"cells":[93,98],"(PBMCs)":[94],"(SMCs).":[99],"Exposure":[100],"ratios":[101,142,170,189],"SP:BP,":[103],"SMC:PBMC":[104],"IM:EN":[106,188],"calculated":[108],"from":[109],"PK":[110,198],"parameters":[111],"generated":[112],"by":[113],"noncompartmental":[114],"analysis.":[115],"load":[118],"was":[119,199],"SP.":[124],"RESULTS:":[125],"Sixteen":[126],"(n=8,":[128],"TDF/FTC;":[129],"n=8,":[130],"TAF/FTC)":[131],"eight":[133],"(TDF/FTC)":[135],"Median":[139],"TFV":[140,154,161],"SP:BP":[141],"differed":[143],"between":[144],"TDF":[145],"TAF":[147,158,196],"(1.5":[148],"versus":[149],"7.4),":[150],"due":[151],"lower":[153],"coupled":[159],"SP":[162,197],"similar":[164],"TDF.":[166],"FTC":[167],"SP:":[168],"approximately":[172],"3.":[173],"SMC":[174,202],"IMs":[177],"ENs":[179],"fraction":[182],"PBMC":[184],"(1-22%),":[186],"though":[187],"exceed":[190],"suggested":[192],"protective":[193],"threshold.":[194],"CONCLUSIONS:":[195],"unexpected.":[200],"IM":[201],"low":[205],"relative":[206],"PBMC,":[208],"as":[209],"EN":[211],"concentrations,":[212],"suggesting":[213],"differences":[214,224],"cell":[216],"phenotype":[217,226],"lineage":[219],"the":[221],"MGT;":[222],"these":[223],"pharmacology":[228],"may":[229],"have":[230],"an":[231],"impact":[232],"on":[233],"selecting":[234],"dosing":[236],"ARVs":[237],"cure":[240],"strategies.":[241]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2018-11-09T00:00:00"}